Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LeishMal

Financiado

Cerrado

Immune-mediated reciprocal impact of concomitant infection by Plasmodium and Lei...

Immune-mediated reciprocal impact of concomitant infection by Plasmodium and Leishmania parasites Malaria and Visceral Leishmaniasis (VL) are prevalent parasitic diseases presenting substantial healthcare challenges in tropical and subtropical endemic regions. They share similar geographical distributions, increasing susceptib... ver más

31/05/2026

iMM

Presupuesto desconocido

Líder del proyecto

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-06-01

HORIZON-WIDERA-2023-TALENTS-02-01: ERA Fellowships ExpectedOutcome:This action builds on the MSCA Postdoctoral Fellowships 2023 action (HORIZON-MSCA-PF...

I+D

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

iMM

Lider

Proyectos interesantes

BES-2017-081657

Medical Technol...

Parasitology

93K€ Cerrado

SAF2008-00743

Medical Technol...

Immunology

121K€ Cerrado

GUTTRYP

Medical Technol...

Infectious Dise...

294K€ Cerrado

SPARCL

Medical Technol...

Data Science

1M€ Cerrado

BES-2010-038427

Medical Technol...

Parasitology

43K€ Cerrado

SAF2013-47556-R

Medical Technol...

Public Health

Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 23 meses Fecha Inicio: 2024-06-01
Fecha Fin: 2026-05-31

Líder del proyecto

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Malaria and Visceral Leishmaniasis (VL) are prevalent parasitic diseases presenting substantial healthcare challenges in tropical and subtropical endemic regions. They share similar geographical distributions, increasing susceptibility during co-infections. Utilizing my multidisciplinary expertise in molecular and cellular biology and parasitology, this research proposal aims to establish a novel murine co-infection model to elucidate the cellular and immunological events during concomitant infection with Plasmodium and Leishmania parasites. Unlike previous studies, we seek to evaluate how Plasmodium affects VL pathology and how Leishmania impacts malaria, providing insights into the disease progression dynamics. Furthermore, we will delineate the immunological responses in single- and co-infected mice, shedding light on host immunity in co-infections. To generate a robust and reproducible murine co-infection model, we will optimize infection parameters, including inoculation routes and parasite doses. The co-infection timing will also be systematically manipulated to discern its impact on disease outcomes. This endeavor holds significant potential to advance our understanding of co-infection biology and contribute significantly to the development of clinical management strategies and therapeutic interventions tailored for co-infections in endemic regions. The host institution’s state-of-the-art facilities and the host laboratory’s extensive experience in investigating co-infections involving Plasmodium and other pathogens ensure an ideal environment for achieving the goals. Ultimately, this project will enable me to become proficient in the field of co-infection biology, encompassing all phases of malaria, including liver, blood, and insect stages. Overall, the research proposal leverages a carefully controlled murine model to illuminate the intricate dynamics of co-infections, contributing to improved healthcare outcomes in regions where these diseases prevail.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores